Research & Development (Pharma & Healthcare)

Pharma & Healthcare R&D Reports

Research & Development (Pharma & Healthcare) Market Research Reports, Industry Analysis and Trends

 

Publication Single User License (PDF) Price
Competitor Analysis: Cardiometabolic Peptides

Competitor Analysis: Cardiometabolic Peptides

Date Published: Nov 12 2014
The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in the development pipeline of peptide therapeutics for treatment of diabetes, obesity and atherosclerosis. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
 
$499.00
Competitor Analysis: Cancer Peptides

Competitor Analysis: Cancer Peptides

Date Published: Nov 12 2014
The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
 
$499.00
Peptide Therapeutics Pipeline Database: 1-Year Subscription

Peptide Therapeutics Pipeline Database: 1-Year Subscription

Date Published: Nov 12 2014
Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files.
 
$997.00
Competitor Analysis: Cardiovascular Peptides

Competitor Analysis: Cardiovascular Peptides

Date Published: Nov 7 2014
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date.
$381.00
Novo Nordisk Partnering 2009-2014

Novo Nordisk Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Novo Nordisk and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Novo Nordisk report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Novo Nordisk and its partnering interests and activities over the past five years.

$995.00
Epilepsy Partnering 2009-2014

Epilepsy Partnering 2009-2014

Date Published: Nov 1 2014

The Epilepsy Partnering 2009-2014 report provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in epilepsy partnering deals
Top epilepsy deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The Epilepsy Partnering 2009-2014 provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies .

$695.00
Hearing Disorders Partnering 2009-2014

Hearing Disorders Partnering 2009-2014

Date Published: Nov 1 2014

Hearing Disorders Partnering 2009-2014 report provides understanding and access to the Hearing disorders partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
Hearing Disorders Partnering 2009-2014 report provides understanding and access to the Hearing disorders partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00
Aspen Partnering 2009-2014

Aspen Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Aspen and its partnering interests and activities over the past seven years

Description
This report provides all the information you require to better understand Aspen and its partnering interests and activities over the past seven years.

$995.00
Valeant Partnering 2009-2014

Valeant Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Valeant and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Valeant 2005-2014 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Valeant and its partnering interests and activities over the past seven years.

$995.00
Anemia Partnering 2009-2014

Anemia Partnering 2009-2014

Date Published: Nov 1 2014

The Anemia Partnering 2009-2014 report provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in anemia partnering deals
Top anemia deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The Anemia Partnering 2009-2014 provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00
Essilor Pharmaceuticals Partnering 2009-2014

Essilor Pharmaceuticals Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Essilor and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Essilor 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Essilor and its partnering interests and activities over the past seven years.

$995.00
Coronary Artery Disease Partnering 2009-2014

Coronary Artery Disease Partnering 2009-2014

Date Published: Nov 1 2014

The Coronary Artery Disease Partnering 2009-2014 report provides understanding and access to the coronary artery disease partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in coronary artery disease partnering deals
Top coronary artery disease deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

$995.00
Nutrition and Vitamin Partnering 2009-2014

Nutrition and Vitamin Partnering 2009-2014

Date Published: Nov 1 2014

Nutrition & Vitamins Partnering 2009-2014 report provides understanding and access to the nutrition & vitamins partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in nutrition & vitamins partnering deals
Top nutrition & vitamins deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

$1,795.00
Conjunctivitis Partnering 2009-2014

Conjunctivitis Partnering 2009-2014

Date Published: Nov 1 2014

Conjunctivitis Partnering 2009-2014 report provides understanding and access to the conjunctivitis partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
Conjunctivitis Partnering 2009-2014 report provides understanding and access to the conjunctivitis partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in conjunctivitis partnering deals
•Top conjunctivitis deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type

$695.00
Biomarker Partnering Terms and Agreements

Biomarker Partnering Terms and Agreements

Date Published: Nov 1 2014

The Biomarker Partnering Terms & Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.

$2,995.00
Ranbaxy Partnering 2009-2014

Ranbaxy Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Ranbaxy and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Ranbaxy 2009-2014 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Ranbaxy and its partnering interests and activities over the past seven years.

$995.00
Psoriasis Partnering 2009-2014

Psoriasis Partnering 2009-2014

Date Published: Nov 1 2014

Psoriasis Partnering 2009-2014 report provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare companies

Description
Psoriasis Partnering 2009-2014 report provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in psoriasis partnering deals
•Top psoriasis deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type

$695.00
Biota Partnering 2009-2014

Biota Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Biota and its partnering interests and activities over the past seven years

Description
The Partnering Agreements with Biota 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Biota and its partnering interests and activities over the past seven years.

$995.00
Breast Cancer Partnering 2009-2014

Breast Cancer Partnering 2009-2014

Date Published: Nov 1 2014

The Breast Cancer Partnering 2009-2014 report provides understanding and access to the breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in breast cancer partnering deals
Top breast cancer deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The Breast Cancer Partnering 2009-2014 provides understanding and access to the breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

$995.00
Viral Partnering Terms and Agreements

Viral Partnering Terms and Agreements

Date Published: Nov 1 2014

The Viral Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the viral partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in viral partnering deals
Average deal terms for headline, upfront and royalty by stage of development
Viral partnering agreement structure
Viral partnering contract documents
Top viral deals by value
Most active viral dealmakers

$995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data